Cas:1351373-50-6 Bis-propargyl-PEG12 manufacturer & supplier

We serve Chemical Name:Bis-propargyl-PEG12 CAS:1351373-50-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Bis-propargyl-PEG12

Chemical Name:Bis-propargyl-PEG12
CAS.NO:1351373-50-6
Synonyms:MFCD28334510;4,7,10,13,16,19,22,25,28,31,34,37,40-Tridecaoxatritetraconta-1,42-diyne
Molecular Formula:C30H54O13
Molecular Weight:622.742
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:623.4±50.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.467
PSA:
Exact Mass:622.356445
LogP:-3.28

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like MFCD28334510 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4,7,10,13,16,19,22,25,28,31,34,37,40-Tridecaoxatritetraconta-1,42-diyne physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,7,10,13,16,19,22,25,28,31,34,37,40-Tridecaoxatritetraconta-1,42-diyne Use and application,4,7,10,13,16,19,22,25,28,31,34,37,40-Tridecaoxatritetraconta-1,42-diyne technical grade,usp/ep/jp grade.


Related News: Joan Merrill, Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology Research Program, US, said: “Arthritis and rash are the most common and persistent problems in lupus and often have a significant impact on a person’s life. The strength of the data from this analysis is that anifrolumab was found to be consistently effective using three different ways of looking at rash and three different approaches to arthritis. 5-(bromomethyl)-2-methylpyrimidin-4-amine manufacturers That site will also tap robotics and virtual reality training, which Takeda says should help operators “learn in a virtual environment before they enter the real facility.” 1-Phenylcyclopropanecarboxylic acid suppliers So-called “off” periods occur when a Parkinson’s patient has difficulty moving about and occur when the effect of the last dose of another common Parkinson’s drug, known as levodopa, wears off. N-(2-Chloropyridin-4-yl)acetamide vendor & factory.